Showing posts with label fallopian tube cancer. Show all posts
Showing posts with label fallopian tube cancer. Show all posts

Wednesday, September 9, 2020

September 9, 2020 - Rare Ovarian and Rare Gynecologic Cancers Chat

Tonight we were joined by 34 participants - survivors, advocates and health care providers - to chat about Rare Ovarian and Rare Gynecologic Cancers. While the NCI defines a rare cancer as a cancer that occurs in 15 out of 100,000 people each year, other definitions are used by different organizations and in other parts of the world. 

Advice about finding health care providers who treat rare cancers included: 

"Finding providers with experience with these cancers can be tough, but can be key to overall treatment and survival per studies." 

"It is really important to ask your provider how many of these cases they have seen - and consider referral to a cancer center that has expertise. " 

"With the rapid adoption of Telehealth, my hope is that all rare cancer patients will soon be able to consult (at least by video) with an expert in their disease."

You may find the transcript here and additional analytics here

Here are some highlights from each topic question. 

T1: What are the rare ovarian cancers types? How do they differ from the more common type? How do treatment and symptoms differ? 

  • T1 Low grade #ovca - low chromosome instability, KRAS, BRAF, ERBB2 mutations with slow tumor development.  https://t.co/T4bJO8Rloa
  • T1 Low grade patients receive either carboplatin + paclitaxel followed by endocrine therapy or endocrine therapy alone. Endocrine therapy: letrozole , anastrozole, tamoxifen  https://t.co/2wimorqtmh
  • Some rare subtypes of ovarian cancer may be associated w/ (also rare) hereditary cancer syndromes while other rare subtypes have no known hereditary cause. Ask your healthcare team if you should meet w/ a genetic counselor for a hereditary cancer risk assessment #gyncsm
  • Facebook has 2 groups for ovarian germ cell patients - Germ Cell Ovarian Cancer Support Group and Germ Cell Tumor Parent Network. 
  • Our research center @sloan_kettering seeks to understanding how patients with ovarian cancer differ with the goal of developing more customized therapies. As below, we have now genetically analyzed over 1800 ovarian tumors. 

T2: Two other rare gyn cancers are vulvar and vaginal cancer. How are they diagnosed and how significant is the role of surgery? Any special treatments available for those cancers?

  • A2: Vulvar and vaginal cancer are rare. Ask your doctor if something doesn't feel right (especially after menopause)! You might need a biopsy. Treatment is very individual based upon the site of the cancer
  • Anatomically surgical treatment might be limited by how close the bowel and/or bladder can be to the tumor. Often radiation with or without chemotherapy is recommended.
  • T2. Different types of #sarcoma can also occur in the vagina (as mine did) and the vulva. When systemic therapy -- such as chemo & targeted treatment -- is needed, sarcoma is generally treated by its subtype, rather than its location in the body. 
  • T2 Vulvar Cancer Symptoms: A lump or growth in or on the vulvar area or groin, patch of skin differently textured or colored, Persistent itching, pain, soreness, or burning in the vulvar area @cancerdotnet 
  • I teach our trainees, when in doubt - biopsy. Vulvar cancer can look very different for each patient. Better to be conservative!

T3: Last month we talked about endometrial cancer. How does uterine sarcoma differ from other cancers of the uterus?

T4: In the past we have talked about ovarian cancer developing in the fallopian tubes yet there is also a fallopian tube cancer. Does it differ from ovarian? Do treatments differ?

  • In general, fallopian tube cancers are treated just like #ovariancancer - similar surgery, chemotherapy, and targeted therapy options 
  • Fallopian tube, ovarian and primary peritoneal cancer should be bundled by their histologic appearance (how they look under the microscope) rather than the site at which the tumor is identified. If you look hard enough most ovarian cancers will have originated in the tube 
  • T4 This gives a good overview of Treatments for Fallopian tube cancer  https://emedicine.medscape.com/article/2056981-overview

T5: What is Gestational Trophoblastic Disease? Are there symptoms? What are the best treatments?

  • T5 via @DanaFarber there are 3 types of GTD : Hydatidiform mole, or molar pregnancy, Choriocarcinoma, Placental-site and epithelioid trophoblastic tumors 
  • A5: Gestational trophoblastic disease is a neoplasm arising from the placenta. For some women this will resolve with time, others need treatment with chemotherapy. 
  • Gestational trophoblastic disease is an abnormal growth & development of the cells that usually form the placenta during pregnancy. The most common initial symptoms are heavy bleeding early in pregnancy. 
  • Sometimes it can be suspected on an ultrasound early in pregnancy. Usually a D&C is done to remove the abnormally developing cells. This usually is all that is needed to treat GTD.
  • However, sometimes GTD can develop into an invasive cancer. There are a few types, but these are collectively termed gestational trophoblastic neoplasia.
  • If this happens, GTN can be treated with chemotherapy (often methotrexate). In fact, GTN was one of the first cancers even to be successfully treated with chemotherapy.
  • GTD — also know and complete or partial molar pregnancies — develops after 1-3 per 1000 pregnancies. The main risks include maternal age (both older and younger) and if the person has ever experienced GTD before.
  • Rarely, this is a life threatening disease. Multidrug chemotherapy is prescribed, sometimes with radiation. Choriocarcinoma can be diagnosed anytime after a pregnancy (normal or miscarriage) and the diagnosis can be tricky.
T6: Primary peritoneal cancer is treated like ovarian cancer. How do they differ?

T7: What are the challenges of having a rare type of cancer? What are some tips and resources when dealing with a rare cancer?

  • T7 Challenge- Finding other patients with the same dx to offer advice and support. When I was initially dx I had trouble finding another Stage 3 OC patient to talk to. Thankfully I reach out to @CancerHopeNet and made my first connection. #gyncsm
  •  I think many of us are proponents of shared-decision making and collaboration between doctor and patient. You want a specialist with knowledge of your type of #gyncsm but you also want one that recognizes you know your body and your exact experience/goals best.

 

Christina and I are so happy to celebrate #gyncsm's 7th Anniversary with everyone tonight. 


We will not be chatting in October but look forward to seeing you on November 11 at 9pm ET when @LHavrilesky @ShelbyDReed will be joining us to get input for a shared decision aid re: ovarian cancer and PARP inhibitors.  


Stay well and safe. 

Dee


Friday, September 4, 2020

Rare Ovarian and Gynecologic Cancers

Happy Gynecologic Cancer Awareness Month! 


This month we will be chatting about Rare Ovarian Cancers and Rare Gynecologic Cancers. We hope you will join us on Wednesday, September 9, at 9pm ET (8pm CT, 6pm PT). 

Did you know that many gynecologic cancers are considered rare diseases in the US and globally? 

There will be an estimated 21,750 women diagnosed with Ovarian Cancer in the US in 2020. Eighty-five to ninety percent of all ovarian cancers are epithelial ovarian cancer. Sub-types include mucinous, endometrioid, clear cell, and undifferentiated. Beyond epithelial, cancerous germ cell tumors make up about 1-2% of ovarian cancers and sex cord-stromal tumors account for about 1% of ovarian cancers. (https://www.cancercenter.com/cancer-types/ovarian-cancer/types)

Primary Peritoneal Cancer, which develops in the lining of the abdomen and pelvis, along with Fallopian Tube Cancer are treated like ovarian cancer and are both considered rare cancers. 

About 6 of every million women in the US are diagnosed with Uterine Leiomysarcoma. (https://www.curesarcoma.org/patient-resources/sarcoma-subtypes/uterine-leiomyosarcoma/)

Gestational Trophoblastic Disease accounts for less than 1% of all gynecologic cancers. (https://www.cancer.net/cancer-types/gestational-trophoblastic-disease/statistics)

In 2020 almost 6,120 women are expected to be diagnosed with Vulvar Cancer in the US (https://www.cancer.net/cancer-types/vulvar-cancer/statistics) while 6,230 women are expected to be  diagnosed with Vaginal Cancer. (https://www.cancer.net/cancer-types/vaginal-cancer/statistics

Additional Source: https://seer.cancer.gov

Join us as we discuss the symptoms and treatment of these rare cancers.

T1: What are the rare ovarian cancers types? How do they differ from the more common type? How do treatment and symptoms differ? 

T2: Two other rare gyn cancers are vulvar and vaginal cancer. How are they diagnosed and how significant is the role of surgery? Any special treatments available for those cancers?

T3: Last month we talked about endometrial cancer. How does uterine sarcoma differ from other cancers of the uterus?

T4: In the past we have talked about ovarian cancer developing in the fallopian tubes yet there is also a fallopian tube cancer. Does it differ from ovarian? Do treatments differ?

T5: What is Gestational Trophoblastic Disease? Are there symptoms? What are the best treatments?

T6: Primary peritoneal cancer is treated like ovarian cancer. How do they differ?

T7: What are the challenges of having a rare type of cancer? What are some tips and resources when dealing with a rare cancer? 

We are also happy to be celebrating our 7th anniversary as a Twitter Chat Community. Christina and I appreciate the support promoting and participating in our chats through the years. 



See you on Wednesday!

Dee

Sunday, August 13, 2017

#Dazzle4Rare - Rare Disease Campaign 2017




We are pleased to once again support the #Dazzle4Rare Campaign sponsored by @hesaonlineorg. Last year was the first time we partnered with #Dazzle4Rare to raise awareness of rare diseases. You may read least year's blog post here.

A number of gynecologic cancers are considered rare diseases by the NIH. Ovarian, Endometrial/Uterine, Fallopian Tube, Vaginal and Vulvar Cancers are rare as are the two gynecologic cancers we discussed during this month's chat, Primary Peritoneal and Gestational Trophoblastic Disease. 

You may learn more about how you can get involved in this year's #Dazzle4Rare Campaign at  https://www.daycause.com/hesaonlineorg/dazzle4rare-2017

Feel free to share tweets like this one from August 13 to the 20th.

#Dazzle4Rare Learn about PPC & GTD rare gynecologic cancers http://gyncsm.blogspot.com/2017/08/august-92017-chat-you-never-heard-of.html #gyncsm

or

#Dazzle4Rare Vulvar, Vaginal and Fallopian Tube are rare gyn cancers   http://gyncsm.blogspot.com/2016/02/february-chat-rare-gyn-cancers-vuvlar.html #gyncsm

If you would like to share your story with a rare gynecologic disease with the #gyncsm community please e-mail us.


Dee and Christina
Founders, #gyncsm Community

Wednesday, February 10, 2016

February Chat : Rare Gyn Cancers- Vulvar, Vaginal and Fallopian Tube Cancers

With Rare Disease Day coming up on February 29th we were pleased to hold a chat on three of the rare gynecologic cancers - Vulvar, Vaginal and Fallopian Tube. Visit www.rarediseaseday.org and follow @rarediseaseday to learn how you can support their efforts to give a voice to rare diseases.


For this month's chat we had forty-six participants join us and we had over 1.5 million impressions. Additional chat statistics may be found here and a complete transcript may be found here.

A sample of responses to our questions appear below:

T1: What are some of the key things to know about vulvar cancer - risks, symptoms, treatments, etc.?

  • Vulvar: estimated 5000 women will be dx with vulvar cancer in 2016. That is 1 in 333 women.Data: via @theNCI SEER data.
  • Vulvar Cancer is classified into three main types, Squamous cell carcinoma, Adenocarcinoma, and Melanoma.                                
  • via @MayoClinic Lichen sclerosus - uncommon condition that creates patchy, white skin that's thinner than normal.
  • T1: Vulvar Cancer treatment: Main - Surgery (laser, excision, vulvectomy) Also - Radiation and/or Chemo
  • @NCCNnews Vulvar guideline for professionals available. Patients can register on site to gain access. 

T2: What are some of the key things to know about vaginal cancer - risks, symptoms, treatments, etc.?

  • Vaginal Cancer: @ACS estimated 4070 women would be dx with vaginal cancer in 2015.
  • Main Vaginal Cancer Symptoms per @CDCgov: abnormal vaginal bleeding or discharge and changes in bathroom habits
  • The pessary is placed into the vagina to support the uterus or bladder and rectum helps decrease urine leakage.
  • Vaginal cancers are similar to cervical cancer in risk factors (HPV and smoking) and treatment (chemoradiation) 
  • Laser and excision for vaginal precancer. Chemoradiation for cancer.

T3: What are some of the key things to know about fallopian tube cancer - risks, symptoms, treatments, etc.?

  • Fallopian Tube: @cancerdotnet in 2013 stated FT cancer is 1% of reproductive cancers. There is a close link to #Ovca
  • #fallopian tube cancer is often treated just like ovarian or peritoneal cancers
  • Fallopian tube cancers can be associated with #BRCA syndrome - just like ovarian cancer!
  • As much as 40% of what we call ovarian cancer may actually be fallopian tube cancer. There are both treated with surg and chemo
  • Most epithelial #ovariancancer cases originate in the fimbria of the Fallopian tubes

T4: There is a suspected relationship between the fallopian tubes and ovarian cancer. What is the latest research showing?

  • There are data to support that #ovarian cancer arises in the fallopian tube
  • Research •role of fallopian tube to ovarian cancer https://t.co/tgtPuYptUP
  • Primary peritoneal cancer is another rare gyn cancer and is similar to ovarian and fallopian tube.

T5: How does the treatment of these cancers differ from that of other GYN cancers (ovarian/cervical/uterine)?

  • Treatment for recurrent vaginal and vulvar cancers is often extrapolated from cervical cancer trials
  • For ovarian, see surgery, benefit of IP chemo, and main-line little or no radiation.

T6: Since these cancers are so rare, where can those impacted by vulvar, vagina, and tubal cancers find information and support? 


Please scroll down for Resources shared during the chat. 

You may continue our conversation about Rare Gyn Cancers on Smart Patients at https://www.smartpatients.com/gyncsm.

Be sure to join us on Wednesday, March  2016 at 9pmET for our discussion on Genetic Counselors and Understanding Cancer Risk. Our guests will be the leadership of National Society of Genetic Counselors (@GeneticCouns). 

We look forward to seeing you then. 

Dee
#gyncsm co-moderator


RESOURCES

Vulvar Cancer 
New NCCN Guidelines published for #VulvarCancer https://t.co/NwdwHbUco5
@GYNCancer ‘s video What Every Woman Should Know: Vulvar Cancer https://t.co/JcoRpGH9wU
@MayoClinic support for those w/ vulvar DX https://t.co/eUAKY1voiG
@CDCChronic has some stories too https://t.co/k8hQKJI6vR
@cancercompass has a message board Vulvar Cancer Discussions; https://t.co/G6spao9P9D

Vaginal Cancer 
#VaginalCancer Treatment (PDQ)—Patient Version - Via @theNCI https://t.co/jOqEbHFq1W
Vaginal Cancer on @CancerDotNet https://t.co/LY10V9PL8v
@GYNCancer   https://t.co/yfB4mOm46L
Vaginal Cancer Info via

Fallopian Tube Cancer 
Fallopian Tube Cancer on @CancerDotNet https://t.co/lPQiPfVbSv
Survivor Story Tina http://eyesontheprize.org/stories/tinap.html
Incidence of Ovarian, Peritoneal, and Fallopian Tube Carcinomas in the United States, 1995–2004 https://t.co/3jISJgbVDu
Research •role of fallopian tube to ovarian cancer https://t.co/tgtPuYptUP
The Role of the Fallopian tube in Ovarian Cancer https://t.co/Rnsdeg6OKf

Rare Diseases
@rarediseaseday https://t.co/e97o9NYSKs
#RareDisease Week on Capitol Hill https://t.co/4CNOLkCbTc
@GlobalGenes 

General 
What Every Woman Should Know video campaign https://t.co/sd3l492Rdx    
Gyn Cancer Symptoms Chart  https://t.co/2B0kOOXKru                        

Friday, February 5, 2016

Rare Gyn Cancer Chat - February 10, 2016



February 29th is Rare Disease Day. In the past, we have tweeted about Rare Disease Day (#RareDiseaseDay) as well as shared information about the day on our blog (here and here). A disease is rare in the U.S. if the "disease or disorder ... affects fewer than 200,000 Americans at any given time." (http://www.rarediseaseday.org/)

The mission of #gyncsm is to support those impacted by all gynecologic cancers. One way we can do this is to offer information on rare gynecologic cancers and support survivors of those cancers. On February 10, 2016 we will be discussing Vulvar, Vaginal and Fallopian Tube cancers. 

An estimated 5,000 women in the U.S. will be diagnosed with Vulvar cancer in 2016. In 2015, it was estimated that 4,070 women would be diagnosed with Vaginal cancer. Around 300 to 400 women are diagnosed annually in the U.S. with Fallopian Tube cancer.  

Join us as we discuss these diseases. The topic questions are:
T1: What are some of the key things to know about vulvar cancer - risks, symptoms, treatments, etc.?

T2: What are some of the key things to know about vaginal cancer - risks, symptoms, treatments, etc.?

T3: What are some of the key things to know about fallopian tube cancer - risks, symptoms, treatments, etc.?

T4: There is a suspected relationship between the fallopian tubes and ovarian cancer. What is the latest research showing?

T5: How does the treatment of these cancers differ from that of other GYN cancers (ovarian/cervical/uterine)?

T6: Since these cancers are so rare, where can those impacted by vulvar, vagina, and tubal cancers find information and support? 


To prepare for the chat you may check these resources from Cancer.net:
Vulvar cancer: http://www.cancer.net/cancer-types/vulvar-cancer
Vaginal cancer: http://www.cancer.net/cancer-types/vaginal-cancer/overview
Fallopian Tube cancer: http://www.cancer.net/cancer-types/fallopian-tube-cancer


We hope you will join us as we raise awareness of the risks of these rare gynecologic cancers, support the women impacted by them, and support the clinicians and researchers who focus on treating these rare cancers. We look forward to your participation in this important discussion on February 10th at 9pm ET (8pm CT/ 6pm PT)


Dee
#gyncsm co-moderator

Friday, January 9, 2015

January Chat Topic Questions : Gynecologic Cancer Risk Factors

Happy New Year!

We begin this year's chats on January 14, 2015 at 9 pm EST. We will be discussing the risk factors for gynecologic cancers. "risk factor is anything that increases a person’s chance of developing cancer." - @cancerdotnet.  


Following the questions you will find links to information from Cancer.Net, the Mayo Clinic and the Foundation for Women's Cancer on the risk factors of each gynecologic cancer.


Topic Questions:
T1A: Are you aware of the risk factors for gyn cancers? When did you learn them? How have they influenced your health decisions?
T1B: Providers - Have your patients asked you about risk factors before or after diagnosis?

T2: Viral infections caused by HPV virus raise risk for cervical, vaginal & vulvar cancers. What do women & parents need to know?

T3: What is DES (Diethystibestrol)? How are women exposed to the hormone? What are the risks?

T4: Genetics are thought to account for as much as 25% of GYN cancers. BRCA has received media attn. What are other genetic risks?

T5: Have you tried to reduce your risk for cancer, recurrence or other cancers? What can women do w/ the info about risk factors?



Links for Gyn Cancer Risks:

Risk factors for ovarian cancer  from @cancerdotnet http://www.cancer.net/cancer-types/ovarian-cancer/risk-factors-and-prevention

Risk factors for cervical cancer from @cancerdotnet

Risk factors for uterine cancers from @cancerdotnet

Risk factors for endometrial cancer from @MayoClinic

Risk factors for fallopian tube cancer @cancerdotnet

Risks for vaginal cancer from @cancerdotnet

Risk for vulvar cancer from @MayoClinic

Risks for GTD @GYNcancer

Risks for #primaryperitoneal cancer @GYNcancer

We look forward to having you join us. 

Dee
Co-moderator